Cover Image

Author correction to 'Actively priming autophagic cell death with novel transferrin receptor-targeted nanomedicine for synergistic chemotherapy against breast cancer' [Acta Pharmaceutica Sinica B 2019; 9(5):1061-1077]

Saved in:

Bibliographic Details
Main Authors:	Dong Mei (Author), Binlong Chen (Author), Bing He (Author), Haibin Liu (Author), Zhiqiang Lin (Author), Jialiang Lin (Author), Xiaoyan Zhang (Author), Ning Sun (Author), Libo Zhao (Author), Xiaoling Wang (Author), Qiang Zhang (Author)
Format:	Book
Published:	Elsevier, 2020-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Actively priming autophagic cell death with novel transferrin receptor-targeted nanomedicine for synergistic chemotherapy against breast cancer
by: Dong Mei, et al.
Published: (2019)

Author correction to "Identification of the dietary supplement capsaicin as an inhibitor of Lassa virus entry" [Acta Pharmaceutica Sinica B 10 (2020) 789-798]
by: Ke Tang, et al.
Published: (2024)

Author correction to 'Approved HIV reverse transcriptase inhibitors in the past decade' [Acta Pharmaceutica Sinica B 12 (2022) 1567-1590]
by: Guangdi Li, et al.
Published: (2023)

Erratum to "Identification of anti-Mycobacterium tuberculosis agents targeting the interaction of bacterial division proteins FtsZ and SepFe" [Acta Pharmaceutica Sinica B 13 (2023) 2056-2070]
by: Hongjuan Zhang, et al.
Published: (2023)

Author correction to "Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors" [Acta Pharmaceutica Sinica B 12 (2022) 4501-4518]
by: Yuling Mao, et al.
Published: (2024)

Author correction to 'Establishment of pseudovirus infection mouse models for in vivo pharmacodynamics evaluation of filovirus entry inhibitors' [Acta Pharmaceutica Sinica B 8 (2018) 200-208]
by: Qing Chen, et al.
Published: (2020)

Author correction to 'Protective effects of VMY-2-95 on corticosterone-induced injuries in mice and cellular models' [Acta Pharmaceutica Sinica B 11 (2021) 1903-1913]
by: Ziru Yu, et al.
Published: (2023)

Author correction to "Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers" [Acta Pharmaceutica Sinica B 11 (2021) 355-372]
by: Tingting Jiang, et al.
Published: (2022)

Author correction to 'Protective effects of VMY-2-95 on corticosterone-induced injuries in mice and cellular models' [Acta Pharmaceutica Sinica B 11(2021) 1903-1913]
by: Ziru Yu, et al.
Published: (2023)

Author correction to "Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles" [Acta Pharmaceutica Sinica B 12 (2022) 1523-1533]
by: Canhao Wu, et al.
Published: (2023)

Author correction to 'Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA' [Acta Pharmaceutica Sinica B 13 (2023) 2585-2600]
by: Wenxin Zhang, et al.
Published: (2023)

Author correction to 'Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects' [Acta Pharmaceutica Sinica B 13 (2023) 2138-2151]
by: Wei Wei, et al.
Published: (2024)

Author correction to "YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer" [Acta Pharmaceutica Sinica B 12 (2022) 2845-2858]
by: Fangfang Lai, et al.
Published: (2023)

Author correction to 'Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases' [Acta pharmaceutica sinica B 12 (2022) 1740-1760]
by: Minyang Fu, et al.
Published: (2022)

Author correction to 'Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling' [Acta Pharmaceutica Sinica B 12 (2022) 1198-1212]
by: Yunhao Wu, et al.
Published: (2022)

Author correction to 'Design, synthesis and biological evaluation of chalcone analogues with novel dual antioxidant mechanisms as potential anti-ischemic stroke agents' [Acta Pharmaceutica Sinica B 9 (2019) 335-350]
by: Jiabing Wang, et al.
Published: (2022)

Author correction to "A nanocleaner specifically penetrates the blood‒brain barrier at lesions to clean toxic proteins and regulate inflammation in Alzheimer's disease" [Acta Pharmaceutica Sinica B 12, (2021) 4032-4044]
by: Ting Lei, et al.
Published: (2022)

Author correction to 'Cardamonin from a medicinal herb protects against LPS-induced septic shock by suppressing NLRP3 inflammasome' [Acta Pharmaceutica Sinica B 9 (2019) 734-744]
by: Zhilei Wang, et al.
Published: (2020)

Author correction to 'TMEM16A inhibits angiotensin II-induced basilar artery smooth muscle cell migration in a WNK1-dependent manner' [Acta Pharmaceutica Sinica B 11 (2021) 3994-4007]
by: Huaqing Zheng, et al.
Published: (2023)

Author correction to 'Ablation of Akt2 and AMPKα2 rescues high fat diet-induced obesity and hepatic steatosis through Parkin-mediated mitophagy' [Acta Pharmaceutica Sinica B 11 (2021) 3508-3526]
by: Shuyi Wang, et al.
Published: (2023)

Author correction to "Coordinated regulation of BACH1 and mitochondrial metabolism through tumor targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapy" [Acta Pharmaceutica Sinica B 12 (2022) 3934-3951]
by: Xuan Yang, et al.
Published: (2023)

Author correction to 'Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis in vivo' [Acta Pharmaceutica Sinica B 11 (2021) 3950-3965]
by: Linglong Deng, et al.
Published: (2023)

Author correction to "DNA damage repair promotion in colonic epithelial cells by andrographolide downregulated cGAS‒STING pathway activation and contributed to the relief of CPT-11-induced intestinal mucositis" [Acta Pharmaceutica Sinica B 12 (2022) 262-273]
by: Yuanyuan Wang, et al.
Published: (2023)

Author correction to 'Herbal formula BaWeiBaiDuSan alleviates polymicrobial sepsis-induced liver injury via increasing the gut microbiota Lactobacillus johnsonii and regulating macrophage anti-inflammatory activity in mice' [Acta Pharmaceutica Sinica B 13 (2023) 1164-1179]
by: Xiaoqing Fan, et al.
Published: (2023)

Motif Dan Kepuasan Pendengar Radio Gapura Klewer 107,7 FM (Studi Komparatif Kesenjangan antara Motif dan Kepuasan Pendengar Radio Gapura Klewer 107,7 FM Surakarta)
by: WIBOWO, Anwar Pukriswanto, et al.
Published: (2015)

Aflatoxin B1 Degradation and Detoxification by Escherichia coli CG1061 Isolated From Chicken Cecum
by: Lingling Wang, et al.
Published: (2019)

Changes to Dermatologica Sinica in 2013
by: Chia-Yu Chu, MD, PhD
Published: (2013)

Folia Pharmaceutica Universitatis Carolinae L/2019
by: Opletalová, Veronika
Published: (2022)

Acknowledgement to Reviewers of Scientia Pharmaceutica in 2017
by: Scientia Pharmaceutica Editorial Office
Published: (2018)

SG-APSIC1061: First-response infection prevention and control during COVID-19 outbreaks in residential aged-care facilities
by: Elizabeth Dawson, et al.
Published: (2023)

Actas
by: Federación Colombiana de Obstetricia y Ginecología
Published: (1957)

Serum Soluble Transferrin Receptor and Transferrin Levels among Regular Blood Donors
by: Samuel K. Appiah, et al.
Published: (2022)

Ferritin, transferrin, and transferrin receptor in relation to metabolic obesity phenotypes: Findings from the China Health and Nutrition Survey
by: Ziyang Ren, et al.
Published: (2022)

Integración internacional de la revista Ars Pharmaceutica
by: Rafael Ruiz-Pérez, et al.

Acknowledgement to Reviewers of <em>Scientia Pharmaceutica </em>in 2019
by: Scientia Pharmaceutica Editorial Office
Published: (2020)

Acknowledgement to Reviewers of <em>Scientia Pharmaceutica</em> in 2018
by: Scientia Pharmaceutica Editorial Office
Published: (2019)

Acknowledgment to Reviewers of <i>Scientia Pharmaceutica</i> in 2021
by: Scientia Pharmaceutica Editorial Office
Published: (2022)

Acknowledgment to the Reviewers of <i>Scientia Pharmaceutica</i> in 2022
by: Scientia Pharmaceutica Editorial Office
Published: (2023)

Acknowledgment to Reviewers of <i>Scientia Pharmaceutica</i> in 2020
by: Scientia Pharmaceutica Editorial Office
Published: (2021)

Investigation of the inhibitory effects of HA-1077 and Y-32885 on the translocation of PKCβI, PKCβII and PKCζ in human neutrophils
by: Xavier Siomboing, et al.
Published: (2001)